Cargando…

CD44s Induces miR-629-3p Expression in Association with Cisplatin Resistance in Head and Neck Cancer Cells

Cisplatin (cis-diamminedichloroplatinum II [CDDP] ) is a well-known chemotherapeutic drug that has been used for the treatment of various types of human cancers, including head and neck cancer. Cisplatin exerts anticancer effects by causing DNA damage, replication defects, transcriptional inhibition...

Descripción completa

Detalles Bibliográficos
Autores principales: Chikuda, Junichiro, Otsuka, Kurataka, Shimomura, Iwao, Ito, Kagenori, Miyazaki, Hiroaki, Takahashi, Ryou-u, Nagasaki, Masahiro, Mukudai, Yoshiki, Ochiya, Takahiro, Shimane, Toshikazu, Shirota, Tatsuo, Yamamoto, Yusuke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226407/
https://www.ncbi.nlm.nih.gov/pubmed/32244823
http://dx.doi.org/10.3390/cancers12040856
_version_ 1783534280366882816
author Chikuda, Junichiro
Otsuka, Kurataka
Shimomura, Iwao
Ito, Kagenori
Miyazaki, Hiroaki
Takahashi, Ryou-u
Nagasaki, Masahiro
Mukudai, Yoshiki
Ochiya, Takahiro
Shimane, Toshikazu
Shirota, Tatsuo
Yamamoto, Yusuke
author_facet Chikuda, Junichiro
Otsuka, Kurataka
Shimomura, Iwao
Ito, Kagenori
Miyazaki, Hiroaki
Takahashi, Ryou-u
Nagasaki, Masahiro
Mukudai, Yoshiki
Ochiya, Takahiro
Shimane, Toshikazu
Shirota, Tatsuo
Yamamoto, Yusuke
author_sort Chikuda, Junichiro
collection PubMed
description Cisplatin (cis-diamminedichloroplatinum II [CDDP] ) is a well-known chemotherapeutic drug that has been used for the treatment of various types of human cancers, including head and neck cancer. Cisplatin exerts anticancer effects by causing DNA damage, replication defects, transcriptional inhibition, cell cycle arrest, and the induction of apoptosis. However, drug resistance is one of the most serious problems with cancer chemotherapy, and it causes expected therapeutic effects to not always be achieved. Here, we analyzed global microRNA (miRNA) expression in CD44 standard form (CD44s)-expressing SAS cells, and we identified miR-629-3p as being responsible for acquiring anticancer drug resistance in head and neck cancer. The introduction of miR-629-3p expression inhibited apoptotic cell death under cisplatin treatment conditions, and it promoted cell migration. Among the computationally predicted target genes of miR-629-3p, we found that a number of gene expressions were suppressed by the transfection with miR-629-3p. Using a xenografting model, we showed that miR-629-3p conferred cisplatin resistance to SAS cells. Clinically, increased miR-629-3p expression tended to be associated with decreased survival in head and neck cancer patients. In conclusion, our data suggest that the increased expression of miR-629-3p provides a mechanism of cisplatin resistance in head and neck cancer and may serve as a therapeutic target to reverse chemotherapy resistance.
format Online
Article
Text
id pubmed-7226407
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-72264072020-05-18 CD44s Induces miR-629-3p Expression in Association with Cisplatin Resistance in Head and Neck Cancer Cells Chikuda, Junichiro Otsuka, Kurataka Shimomura, Iwao Ito, Kagenori Miyazaki, Hiroaki Takahashi, Ryou-u Nagasaki, Masahiro Mukudai, Yoshiki Ochiya, Takahiro Shimane, Toshikazu Shirota, Tatsuo Yamamoto, Yusuke Cancers (Basel) Article Cisplatin (cis-diamminedichloroplatinum II [CDDP] ) is a well-known chemotherapeutic drug that has been used for the treatment of various types of human cancers, including head and neck cancer. Cisplatin exerts anticancer effects by causing DNA damage, replication defects, transcriptional inhibition, cell cycle arrest, and the induction of apoptosis. However, drug resistance is one of the most serious problems with cancer chemotherapy, and it causes expected therapeutic effects to not always be achieved. Here, we analyzed global microRNA (miRNA) expression in CD44 standard form (CD44s)-expressing SAS cells, and we identified miR-629-3p as being responsible for acquiring anticancer drug resistance in head and neck cancer. The introduction of miR-629-3p expression inhibited apoptotic cell death under cisplatin treatment conditions, and it promoted cell migration. Among the computationally predicted target genes of miR-629-3p, we found that a number of gene expressions were suppressed by the transfection with miR-629-3p. Using a xenografting model, we showed that miR-629-3p conferred cisplatin resistance to SAS cells. Clinically, increased miR-629-3p expression tended to be associated with decreased survival in head and neck cancer patients. In conclusion, our data suggest that the increased expression of miR-629-3p provides a mechanism of cisplatin resistance in head and neck cancer and may serve as a therapeutic target to reverse chemotherapy resistance. MDPI 2020-04-01 /pmc/articles/PMC7226407/ /pubmed/32244823 http://dx.doi.org/10.3390/cancers12040856 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Chikuda, Junichiro
Otsuka, Kurataka
Shimomura, Iwao
Ito, Kagenori
Miyazaki, Hiroaki
Takahashi, Ryou-u
Nagasaki, Masahiro
Mukudai, Yoshiki
Ochiya, Takahiro
Shimane, Toshikazu
Shirota, Tatsuo
Yamamoto, Yusuke
CD44s Induces miR-629-3p Expression in Association with Cisplatin Resistance in Head and Neck Cancer Cells
title CD44s Induces miR-629-3p Expression in Association with Cisplatin Resistance in Head and Neck Cancer Cells
title_full CD44s Induces miR-629-3p Expression in Association with Cisplatin Resistance in Head and Neck Cancer Cells
title_fullStr CD44s Induces miR-629-3p Expression in Association with Cisplatin Resistance in Head and Neck Cancer Cells
title_full_unstemmed CD44s Induces miR-629-3p Expression in Association with Cisplatin Resistance in Head and Neck Cancer Cells
title_short CD44s Induces miR-629-3p Expression in Association with Cisplatin Resistance in Head and Neck Cancer Cells
title_sort cd44s induces mir-629-3p expression in association with cisplatin resistance in head and neck cancer cells
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226407/
https://www.ncbi.nlm.nih.gov/pubmed/32244823
http://dx.doi.org/10.3390/cancers12040856
work_keys_str_mv AT chikudajunichiro cd44sinducesmir6293pexpressioninassociationwithcisplatinresistanceinheadandneckcancercells
AT otsukakurataka cd44sinducesmir6293pexpressioninassociationwithcisplatinresistanceinheadandneckcancercells
AT shimomuraiwao cd44sinducesmir6293pexpressioninassociationwithcisplatinresistanceinheadandneckcancercells
AT itokagenori cd44sinducesmir6293pexpressioninassociationwithcisplatinresistanceinheadandneckcancercells
AT miyazakihiroaki cd44sinducesmir6293pexpressioninassociationwithcisplatinresistanceinheadandneckcancercells
AT takahashiryouu cd44sinducesmir6293pexpressioninassociationwithcisplatinresistanceinheadandneckcancercells
AT nagasakimasahiro cd44sinducesmir6293pexpressioninassociationwithcisplatinresistanceinheadandneckcancercells
AT mukudaiyoshiki cd44sinducesmir6293pexpressioninassociationwithcisplatinresistanceinheadandneckcancercells
AT ochiyatakahiro cd44sinducesmir6293pexpressioninassociationwithcisplatinresistanceinheadandneckcancercells
AT shimanetoshikazu cd44sinducesmir6293pexpressioninassociationwithcisplatinresistanceinheadandneckcancercells
AT shirotatatsuo cd44sinducesmir6293pexpressioninassociationwithcisplatinresistanceinheadandneckcancercells
AT yamamotoyusuke cd44sinducesmir6293pexpressioninassociationwithcisplatinresistanceinheadandneckcancercells